Literature DB >> 21180399

Promises and pitfalls in cell replacement therapy for heart failure.

Markus Krane1, Oliver Wernet, Sean M Wu.   

Abstract

Symptomatic heart failure is a complex clinical syndrome with a poor prognosis. Many efforts have been made to develop new therapeutic strategies to improve prognosis associated with heart failure. In this context, different stem cell populations for cardiac regenerative therapy have been examined recently. Here we discuss the potential strategies for using stem cells in cardiac regenerative therapy and the barriers that remain before an effective cell-based cardiac regenerative therapy can be employed clinically.

Entities:  

Year:  2010        PMID: 21180399      PMCID: PMC3003923          DOI: 10.1016/j.ddmec.2010.07.004

Source DB:  PubMed          Journal:  Drug Discov Today Dis Mech        ISSN: 1740-6765


  64 in total

1.  Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes.

Authors:  Manuel Alvarez-Dolado; Ricardo Pardal; Jose M Garcia-Verdugo; John R Fike; Hyun O Lee; Klaus Pfeffer; Carlos Lois; Sean J Morrison; Arturo Alvarez-Buylla
Journal:  Nature       Date:  2003-10-12       Impact factor: 49.962

2.  Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial.

Authors:  Dietlind Zohlnhöfer; Ilka Ott; Julinda Mehilli; Kathrin Schömig; Fabian Michalk; Tareq Ibrahim; Günther Meisetschläger; Jasper von Wedel; Hildegard Bollwein; Melchior Seyfarth; Josef Dirschinger; Claus Schmitt; Markus Schwaiger; Adnan Kastrati; Albert Schömig
Journal:  JAMA       Date:  2006-03-01       Impact factor: 56.272

3.  Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.

Authors:  Volker Schächinger; Sandra Erbs; Albrecht Elsässer; Werner Haberbosch; Rainer Hambrecht; Hans Hölschermann; Jiangtao Yu; Roberto Corti; Detlef G Mathey; Christian W Hamm; Tim Süselbeck; Birgit Assmus; Torsten Tonn; Stefanie Dimmeler; Andreas M Zeiher
Journal:  N Engl J Med       Date:  2006-09-21       Impact factor: 91.245

4.  Mobilized bone marrow cells repair the infarcted heart, improving function and survival.

Authors:  D Orlic; J Kajstura; S Chimenti; F Limana; I Jakoniuk; F Quaini; B Nadal-Ginard; D M Bodine; A Leri; P Anversa
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

5.  Granulocyte colony stimulating factor in patients with large acute myocardial infarction: results of a pilot dose-escalation randomized trial.

Authors:  Stephen G Ellis; Marc S Penn; Brian Bolwell; Mario Garcia; Matthews Chacko; Thomas Wang; Kelly J Brezina; Gerry McConnell; Eric J Topol
Journal:  Am Heart J       Date:  2006-12       Impact factor: 4.749

6.  Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization.

Authors:  B Daan Westenbrink; Erik Lipsic; Peter van der Meer; Pim van der Harst; Hisko Oeseburg; Gideon J Du Marchie Sarvaas; Johan Koster; Adriaan A Voors; Dirk J van Veldhuisen; Wiek H van Gilst; Regien G Schoemaker
Journal:  Eur Heart J       Date:  2007-06-17       Impact factor: 29.983

7.  Regenerating functional myocardium: improved performance after skeletal myoblast transplantation.

Authors:  D A Taylor; B Z Atkins; P Hungspreugs; T R Jones; M C Reedy; K A Hutcheson; D D Glower; W E Kraus
Journal:  Nat Med       Date:  1998-08       Impact factor: 53.440

8.  Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts.

Authors:  Charles E Murry; Mark H Soonpaa; Hans Reinecke; Hidehiro Nakajima; Hisako O Nakajima; Michael Rubart; Kishore B S Pasumarthi; Jitka Ismail Virag; Stephen H Bartelmez; Veronica Poppa; Gillian Bradford; Joshua D Dowell; David A Williams; Loren J Field
Journal:  Nature       Date:  2004-03-21       Impact factor: 49.962

9.  Parathyroid hormone treatment after myocardial infarction promotes cardiac repair by enhanced neovascularization and cell survival.

Authors:  Marc-Michael Zaruba; Bruno C Huber; Stefan Brunner; Elisabeth Deindl; Robert David; Rebekka Fischer; Gerald Assmann; Nadja Herbach; Sebastian Grundmann; Ruediger Wanke; Josef Mueller-Hoecker; Wolfgang-Michael Franz
Journal:  Cardiovasc Res       Date:  2007-11-30       Impact factor: 10.787

10.  In vivo reprogramming of adult pancreatic exocrine cells to beta-cells.

Authors:  Qiao Zhou; Juliana Brown; Andrew Kanarek; Jayaraj Rajagopal; Douglas A Melton
Journal:  Nature       Date:  2008-08-27       Impact factor: 49.962

View more
  5 in total

Review 1.  Cardiac regeneration: current therapies-future concepts.

Authors:  Stefanie A Doppler; Marcus-André Deutsch; Rüdiger Lange; Markus Krane
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

Review 2.  Heart repair and regeneration: recent insights from zebrafish studies.

Authors:  Ching-Ling Lien; Michael R Harrison; Tai-Lan Tuan; Vaughn A Starnes
Journal:  Wound Repair Regen       Date:  2012-07-20       Impact factor: 3.617

3.  Morphometric Analysis of Human Embryonic Stem Cell-Derived Ventricular Cardiomyocytes: Determining the Maturation State of a Population by Quantifying Parameters in Individual Cells.

Authors:  Harvey Y S Chan; Wendy Keung; Ronald A Li; Andrew L Miller; Sarah E Webb
Journal:  Stem Cells Int       Date:  2015-08-17       Impact factor: 5.443

4.  Exendin-4 enhances the migration of adipose-derived stem cells to neonatal rat ventricular cardiomyocyte-derived conditioned medium via the phosphoinositide 3-kinase/Akt-stromal cell-derived factor-1α/CXC chemokine receptor 4 pathway.

Authors:  Hao Zhou; Junjie Yang; Ting Xin; Tao Zhang; Shunyin Hu; Shanshan Zhou; Guanghui Chen; Yundai Chen
Journal:  Mol Med Rep       Date:  2015-01-22       Impact factor: 2.952

5.  Effects of Exendin-4 on bone marrow mesenchymal stem cell proliferation, migration and apoptosis in vitro.

Authors:  Hao Zhou; Dandan Li; Chen Shi; Ting Xin; Junjie Yang; Ying Zhou; Shunyin Hu; Feng Tian; Jing Wang; Yundai Chen
Journal:  Sci Rep       Date:  2015-08-07       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.